484 related articles for article (PubMed ID: 9398703)
1. Characterization of monoclonal thyroid-stimulating and thyrotropin binding-inhibiting autoantibodies from a Hashimoto's patient whose children had intrauterine and neonatal thyroid disease.
Kohn LD; Suzuki K; Hoffman WH; Tombaccini D; Marcocci C; Shimojo N; Watanabe Y; Amino N; Cho BY; Kohno Y; Hirai A; Tahara K
J Clin Endocrinol Metab; 1997 Dec; 82(12):3998-4009. PubMed ID: 9398703
[TBL] [Abstract][Full Text] [Related]
2. Thyrotropin receptor autoantibodies (TSHRAbs): epitopes, origins and clinical significance.
Kohn LD; Harii N
Autoimmunity; 2003; 36(6-7):331-7. PubMed ID: 14669940
[TBL] [Abstract][Full Text] [Related]
3. Epitopes for thyroid stimulating and blocking autoantibodies on the extracellular domain of the human thyrotropin receptor.
Tahara K; Ishikawa N; Yamamoto K; Hirai A; Ito K; Tamura Y; Yoshida S; Saito Y; Kohn LD
Thyroid; 1997 Dec; 7(6):867-77. PubMed ID: 9459630
[TBL] [Abstract][Full Text] [Related]
4. Hashimoto's thyroiditis with heterogeneous antithyrotropin receptor antibodies: unique epitopes may contribute to the regulation of thyroid function by the antibodies.
Akamizu T; Kohn LD; Hiratani H; Saijo M; Tahara K; Nakao K
J Clin Endocrinol Metab; 2000 Jun; 85(6):2116-21. PubMed ID: 10852437
[TBL] [Abstract][Full Text] [Related]
5. Characterization of recombinant monoclonal antithyrotropin receptor antibodies (TSHRAbs) derived from lymphocytes of patients with Graves' disease: epitope and binding study of two stimulatory TSHRAbs.
Akamizu T; Moriyama K; Miura M; Saijo M; Matsuda F; Nakao K
Endocrinology; 1999 Apr; 140(4):1594-601. PubMed ID: 10098493
[TBL] [Abstract][Full Text] [Related]
6. Changes in epitopes for thyroid-stimulating antibodies in Graves' disease sera during treatment of hyperthyroidism: therapeutic implications.
Kim WB; Chung HK; Lee HK; Kohn LD; Tahara K; Cho BY
J Clin Endocrinol Metab; 1997 Jun; 82(6):1953-9. PubMed ID: 9177413
[TBL] [Abstract][Full Text] [Related]
7. Thyrotropin receptor epitopes recognized by graves' autoantibodies developing under immunosuppressive therapy.
Wortsman J; McConnachie P; Tahara K; Kohn LD
J Clin Endocrinol Metab; 1998 Jul; 83(7):2302-8. PubMed ID: 9661599
[TBL] [Abstract][Full Text] [Related]
8. The formation of thyrotropin receptor (TSHR) antibodies in a Graves' animal model requires the N-terminal segment of the TSHR extracellular domain.
Kikuoka S; Shimojo N; Yamaguchi KI; Watanabe Y; Hoshioka A; Hirai A; Saito Y; Tahara K; Kohn LD; Maruyama N; Kohno Y; Niimi H
Endocrinology; 1998 Apr; 139(4):1891-8. PubMed ID: 9528975
[TBL] [Abstract][Full Text] [Related]
9. Epitopes for thyroid-stimulating antibodies in Graves' sera: a possible link of heterogeneity to differences in response to antithyroid drug treatment.
Kim WB; Cho BY; Park HY; Lee HK; Kohn LD; Tahara K; Koh CS
J Clin Endocrinol Metab; 1996 May; 81(5):1758-67. PubMed ID: 8626830
[TBL] [Abstract][Full Text] [Related]
10. Use of cells expressing the human thyrotropin (TSH) receptor for the measurement of thyroid stimulating and TSH-blocking antibodies.
Vitti P; Chiovato L; Fiore E; Mammoli C; Rocchi R; Pinchera A
Acta Med Austriaca; 1996; 23(1-2):52-6. PubMed ID: 8767515
[TBL] [Abstract][Full Text] [Related]
11. Identification of thyroid-stimulating antibody-specific interaction sites in the N-terminal region of the thyrotropin receptor.
Kosugi S; Ban T; Kohn LD
Mol Endocrinol; 1993 Jan; 7(1):114-30. PubMed ID: 8095322
[TBL] [Abstract][Full Text] [Related]
12. Use of thyrotropin receptor (TSHR) mutants to detect stimulating TSHR antibodies in hypothyroid patients with idiopathic myxedema, who have blocking TSHR antibodies.
Kosugi S; Ban T; Akamizu T; Valente W; Kohn LD
J Clin Endocrinol Metab; 1993 Jul; 77(1):19-24. PubMed ID: 8100829
[TBL] [Abstract][Full Text] [Related]
13. Characterization of thyroid-stimulating blocking antibodies that appeared during transient hypothyroidism after radioactive iodine therapy.
Kung AW; Lau KS; Kohn LD
Thyroid; 2000 Oct; 10(10):909-17. PubMed ID: 11081257
[TBL] [Abstract][Full Text] [Related]
14. Subtypes of anti-TSH receptor antibodies classified by various assays using CHO cells expressing wild-type or chimeric human TSH receptor.
Watanabe Y; Tahara K; Hirai A; Tada H; Kohn LD; Amino N
Thyroid; 1997 Feb; 7(1):13-9. PubMed ID: 9086564
[TBL] [Abstract][Full Text] [Related]
15. Identification of separate determinants on the thyrotropin receptor reactive with Graves' thyroid-stimulating antibodies and with thyroid-stimulating blocking antibodies in idiopathic myxedema: these determinants have no homologous sequence on gonadotropin receptors.
Kosugi S; Ban T; Akamizu T; Kohn LD
Mol Endocrinol; 1992 Feb; 6(2):168-80. PubMed ID: 1349156
[TBL] [Abstract][Full Text] [Related]
16. Thyrotropin (TSH) receptor antibodies (TSHrAb) can inhibit TSH-mediated cyclic adenosine 3',5'- monophosphate production in thyroid cells by either blocking TSH binding or affecting a step subsequent to TSH binding.
Dallas JS; Cunningham SJ; Patibandla SA; Seetharamaiah GS; Morris JC; Tahara K; Kohn LD; Prabhakar BS
Endocrinology; 1996 Aug; 137(8):3329-39. PubMed ID: 8754759
[TBL] [Abstract][Full Text] [Related]
17. The prevalence and clinical significance of blocking thyrotropin receptor antibodies in untreated hyperthyroid Graves' disease.
Kim WB; Chung HK; Park YJ; Park DJ; Tahara K; Kohn LD; Cho BY
Thyroid; 2000 Jul; 10(7):579-86. PubMed ID: 10958310
[TBL] [Abstract][Full Text] [Related]
18. Two Graves' disease patients who spontaneously developed hypothyroidism after antithyroid drug treatment: characteristics of epitopes for thyrotropin receptor antibodies.
Chung HK; Kim WB; Park DJ; Kohn LD; Tahara K; Cho BY
Thyroid; 1999 Apr; 9(4):393-9. PubMed ID: 10319947
[TBL] [Abstract][Full Text] [Related]
19. Fetal and neonatal hyperthyroidism and hypothyroidism due to maternal TSH receptor antibodies.
McKenzie JM; Zakarija M
Thyroid; 1992; 2(2):155-9. PubMed ID: 1356056
[TBL] [Abstract][Full Text] [Related]
20. Graves' immunoglobulins activate phospholipase A2 by recognizing specific epitopes on thyrotropin receptor.
Di Cerbo A; Di Paola R; Menzaghi C; De Filippis V; Tahara K; Corda D; Kohn LD
J Clin Endocrinol Metab; 1999 Sep; 84(9):3283-92. PubMed ID: 10487700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
